Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma

Thrombosis Research

Volumn 130, Issue 1, 2012, Pages 7-11

  Yokoyama, Kenji ^a   Murata, Mitsuru ^a   Ikeda, Yasuo ^b   Okamoto, Shinichiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

Japanese; Lymphoma; Performance status; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HEPARIN; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERNATIONAL PROGNOSTIC INDEX; JAPANESE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; UNIVERSITY HOSPITAL; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; JAPAN; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84861818300     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.09.022     Document Type: Article

References (36)

1. P.D. Stein, A. Beemath, F.A. Meyers, E. Skaf, J. Sanchez, and R.E. Olson Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 2006 60 68
2. A.K. Kakkar, M.N. Levine, H.M. Pinedo, R. Wolff, and J. Wong Venous thrombosis in cancer patients: insights from the frontline survey Oncologist 8 2003 381 388
3. P. Prandoni, A. Falanga, and A. Picoli Cancer and venous thromboembolism Lancet Oncol 6 2005 401 410
4. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
5. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 2007 632 634
6. J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venousthrombosis JAMA 293 2005 715 722
7. A.A. Khorana, C.W. Francis, E. Culakova, R.I. Fisher, N.M. Kuderer, and G.H. Lyman Thromboembolism in hospitalized neutropenic cancer patients J Clin Oncol 24 3 2006 484 490
8. A.A. Khorana, C.W. Francis, E. Culakova, and G.H. Lyman Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer 104 12 2005 2822 2829
9. N. Levitan, A. Dowlati, S.C. Remick, H.I. Tahsildar, L.D. Sivinski, and R. Beyth Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 5 1999 285 291
10. S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 4 2002 575 579
11. M. Mohren, I. Markmann, K. Jentsch-Ullrich, M. Koenigsmann, G. Lutze, and A. Franke Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis Br J Cancer 92 8 2005 1349 1351
12. R.S. Komrokji, N.P. Uppal, A.A. Khorana, G.H. Lyman, K.L. Kaplan, and R.I. Fisher Venous thromboembolism in patients with diffuse large B-cell lymphoma Leuk Lymphoma 47 6 2006 1029 1033
13. X. Zhou, S. Teegala, A. Huen, Y. Ji, L. Fayad, and F.B. Hagemeister Incidence and risk factors of venous thromboembolic events in lymphoma Am J Med 123 10 2010 935 941
14. V. Caruso, A. Di Castelnuovo, S. Meschengieser, M.A. Lazzari, G. de Gaetano, and S. Storti Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events Blood 115 26 2010 5322 5328
15. N. Goldschmidt, E. Linetsky, E. Shalom, D. Varon, and T. Siegal High incidence of thromboembolism in patients with central nervous system lymphoma Cancer 98 6 2003 1239 1242
16. D. Lekovic, P. Miljic, and B. Mihaljevic Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma Thromb Res 126 2010 477 480
17. I. Gore, A.E. Hirst, and K. Tanaka Myocardial infarction and thromboembolism Arch Intern Med 113 1964 323 330
18. M. Hirose, and K. Inada Postoperative deep vein thrombosis: early diagnosis and prophylaxis Jpn Circ J 48 1984 111 117
19. R.H. White, H. Zhou, and P.S. Romano Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California Ann Intern Med 128 9 1998 737 740
20. P.D. Stein, F. Kayali, R.E. Olson, and C.E. Milford Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census Am J Med 116 7 2004 435 442
21. M. Sakuma, Y. Konno, and K. Shirato Increasing mortality from pulmonary embolism in Japan, 1951-2000 Circ J 66 2002 1144 1149
22. S. Fujita, S. Hirota, T. Oda, Y. Kato, Y. Tsukamoto, and T. Fuji Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan Clin Orthop 375 2000 168 174
23. M. Sakon, Y. Maehara, H. Yoshikawa, and H. Akaza Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan J Thromb Haemost 4 3 2006 581 586
24. S.Y. Oh, J.H. Kim, K.W. Lee, S.M. Bang, J.H. Hwang, and D. Oh Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity Thromb Res 122 4 2008 485 490
25. Y. Koh, S.M. Bang, J.H. Lee, H.J. Yoon, Y.R. Do, and H.M. Ryoo Korean Multiple Myeloma Working Party. Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide Ann Hematol 89 2 2010 201 206
26. Y. Hattori, S. Okamoto, N. Shimada, T. Kakimoto, K. Morita, and Y. Tanigawara Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: prognostic factors and unique toxicity profile Cancer Sci 99 6 2008 1243 1250
27. A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
28. N. Yamada, S. Ota, Y. Liu, M.M. Crane, C.M. Chang, and S. Thaker Risk factors for nonfatal pulmonary embolism in a Japanese population: A hospital-based case-control study Angiology 61 3 2010 269 274
29. R.H. White The epidemiology of venous thromboembolism Circulation 107 23 suppl 1 2003 I4 I8
30. S.M. Bates, I.A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl 2008 844S 886S
31. G.H. Lyman, A.A. Khorana, A. Falanga, D. Clarke-Pearson, C. Flowers, and M. Jahanzeb American Society of Clinical Oncology American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J Clin Oncol 25 34 2007 5490 5505
32. D. Imberti, M. Di Nisio, M.B. Donati, A. Falanga, A. Ghirarduzzi, and D. Guarneri Italian Society for Thrombosis and Haemostasis Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) Thromb Res 124 5 2009 e32 e40
33. D. Farge, L. Bosquet, D. Kassab-Chahmi, P. Mismetti, I. Elalamy, and G. Meyer SOR. 2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group Crit Rev Oncol Hematol 73 1 2010 31 46
34. M. Ratcliffe, C. Broadfoot, M. Davidson, K.F. Kelly, and M. Greaves Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose VKA in subjects with malignant disease Clin Lab Haematol 21 5 1999 353 357
35. K.E. Sletnes, H. Holte, S. Halvorsen, E. Jakobsen, F. Wisloff, and S. Kvaloy Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma Bone Marrow Transplant 17 4 1996 577 581
36. R. Kimura, S. Honda, T. Kawasaki, H. Tsuji, S. Madoiwa, and Y. Sakata Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients Blood 107 2006 1737 1738